TradingView
TradeWithTyler
May 16, 2019 1:12 AM
CLRB Phase 1 Success
NASDAQ:CLRB
15
Cellectar Biosciences, Inc.
NASDAQ
Description
⋅
May 16, 2019 1:12 AM
Positive news today "CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma". This stock Shs Float is 5.15M, and Market Cap 14.76M.
Trend Analysis
Chart Patterns
Technical Indicators
CLRB
Stocks
More